Connectus Wealth, LLC Myriad Genetics Inc Transaction History

Connectus Wealth, LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 07, 2023	SELL	$14.51 - $20.99 $14,510 - $20,990	-1,000 Reduced 1.18%	83,754 $1.22 Million
Q2 2022 Aug 08, 2022	BUY	$16.45 - $25.88 $1.39 Million - $2.19 Million	84,754 New	84,754 $1.54 Million
Q1 2022 May 06, 2022	SELL	$22.67 - $28.01 $1.92 Million - $2.37 Million	-84,754 Closed	0 $0
Q4 2021 Feb 09, 2022	BUY	$24.13 - $32.63 $2.05 Million - $2.77 Million	84,754 New	84,754 $2.34 Million

253

90.5M

100K

34K

Ticker MYGN
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 80,634,800
Market Cap $1.11B
Description
Myriad Genetics, Inc., a genetic testing and precision medicine company, develops and commercializes genetic tests in the United States and internationally. The company offers molecular diagnostic tests for use in oncology, and women's and mental health applications. It provides MyRisk Hereditary Cancer Test, a DNA sequencing test for assessing ...

Get notified when there are updates to the investment portfolio of Connectus Wealth, LLC, based on Form 13F filings with the SEC.

Stay updated on Connectus Wealth, LLC with notifications on news.